Home › Forums › Main Forum › Media & News › More nausea-inducing news about Gilead’s strategy
- This topic has 81 replies, 25 voices, and was last updated 8 years, 7 months ago by mgalbrai.
-
AuthorPosts
-
21 November 2015 at 11:42 pm #4379
This pharma co is utterly obscene:
ick:' />
22 November 2015 at 12:08 am #4380that’s really disgusting stuff, ugh!
GT 2b; since 80’s, no prior tx, sofosbuvir and daclatasvir compounded from API’s at Kingswood Pharmacy in Sydney, started tx nov 6,2015, undetected at 4 wks, UND at 8 weeks, UND at 1 week after EOT, UND at 4 weeks after EOT and UND at 8 weeks after EOT. I feel GOOD!! I knew that I WOULD!””
22 November 2015 at 12:08 am #4381Alsdad
That was a horrible, nasty read!
gt 1a VL 6m
F2/3 FibroScan – 9KPa in 2011 and 7KPa in 2015
sof/dac 10 December for 12 weeks
pre tx alt 85 ast 51
4 wk alt 34 ast 31 UND <35
8 wk alt 29 ast 32 UND <15
12wk alt 25 ast 25 EOT 3.3.16
SVR24 UND KPa5.3 F0 in normal range
I am well
.forever grateful to fixhepc22 November 2015 at 12:37 am #4382“”Looking ahead in Europe, we anticipate that our HCV revenues will be constrained by country-specific budgets rather than the number of patients in need of treatment.” (This and other quotes courtesy of S&P Capital IQ.)
Put another way, countries will allocate some money each year to hepatitis C, and the remainder of potential patients will have to wait for future years. This means Gilead should be able to count on consistent revenue from Europe for years to come” ……
Welll UK Drs – What are you going to do about that?
GT1a Dec14 F2/8.7 VL 900000-2.5M
Jan16 Hepcivir-L MonkMed/Redemption
Baseline: VL 913575 Alt 76 Platelets low
Wk2 VL1157 Alt 23
DET Wk 8 VL 32 Alt19 ‘In the slow lane’
June16 Fibro 5.7 F0/1 LIF 1.5
Wk 11 VL<12 Alt 13 Det/Unq
Extending tx 12 wks Mylan Sofo/Dac MonkMed
Wk 14 VL <12 Det/Unq
Wk 16 VL UNDETECTED
Wk 22 + 4 Wks Sunprevir FixHepC
Wk 24 UNDETECTED Alt 13
Wk 12 post tx SVR12 Wk 26 SVR24
Thank-you Tim, Dr Debasis @ MonkMed & Dr Freeman @ Fix HepC22 November 2015 at 12:45 am #4385And more getting infected all the time…for a continuing revenue-stream! *fistpump*
The ugly, venal face of capitalism inch:
GT1a since 1988, diagnosed 1990
F0, tx naive
VL 262,000 ALT 40 AST 26 GGT 13 Fibroscan 04/12/15 – 2.9
Started Mesochem sof/dac 12 weeks 01/01/2016
11/02/2016 – 6 weeks UNDETECTED
AST 26
ALT 2622 November 2015 at 12:52 am #4386How breath-takingling callous! Its as if Gilead investors think of us as pork bellies:
https://www.youtube.com/watch?v=YxI8Jdum_9g
https://www.youtube.com/watch?v=ZjDbJQKDXCY
“Randalph, this isn’t monopoly money we’re playing with!”
Diagnosed Jan 2015: GT3, A0+F0/F1. Fatigue + Brain-Fog.
Started Sof+Dac from fixHepC 10-Nov-2015. NO sides.
Pre-Tx: AST 82, ALT 133, Viral Load 1 900 000.
Week4: AST 47, ALT 58. VL < 15 (unquantifiable). Week12 (EOT): AST 30, ALT 26, VL UND Week16 (EOT+4): AST 32, ALT 28, GGT 24, VL UND Week28 (EOT+16): AST 26, ALT 22, GGT 24, VL UND Ever grateful to Dr James. Relapsed somewhere after all that... Bummer! Jan 2018: VL 63 000 (still GT3).22 November 2015 at 12:54 am #4387It’s the blase way the article is written that gets me: Anyone would think he’s discussing something like a high-end car manufacturer with a long waiting list for it’s latest limited edition top-of-the-range sports coupe, rather than people queueing up for obscenely-overpriced medicine to save their lives!
22 November 2015 at 1:47 am #4390Reminds me of this classic old Leunig
GT1a since 1988, diagnosed 1990
F0, tx naive
VL 262,000 ALT 40 AST 26 GGT 13 Fibroscan 04/12/15 – 2.9
Started Mesochem sof/dac 12 weeks 01/01/2016
11/02/2016 – 6 weeks UNDETECTED
AST 26
ALT 2622 November 2015 at 1:59 am #4391I think you will find that that conversation is happening regularly around the world for most of the common drugs pushed in obscene quantities often on spurious/questionable research. The amount of articles and books now being written by PROMINENT players in the field of medical research is getting larger and larger. They all point to the same corruption and criminal greed within the present medical research and marketing of drugs in the world. ie ex editor and sub editor of the British Lancet Journal, one of the founding members of the Cochrane review etc. I have been reading and studying in this area for the last 30 years. It is only when a lot of people all of a sudden due to their own personal circumstances discover this unhealthy truth.
22 November 2015 at 2:09 am #4392And another insider story on this subject. I have a friend who lives in China and is married to a Chinese woman who is a Western medical doctor in the hospital system in a prominent position looking after retired political members.
Every weekend she is offered a holiday in a Chinese holiday destination 5-6 stars. She is also given kickbacks in her pay each time she writes a script for a particular drug and the hospital also receives kickbacks. No matter how you dress this up or what you call the payments they are kickbacks and incentives, and who is going to pull the plug on that? Deep levels of corruption in any other industry. Dont think that this only happens in China! Those companies are multi nationals and when you start to talk of 11 billion profit in 1 year from 1 drug, extrapolate that into a few more dozen drugs. A lot of buying power yes!22 November 2015 at 2:35 am #4395Hi Ann Bee,
Yes, Yes, I could not agree more… I just read “The Truth About The Drug Companies (And How They Deceive Us And What To Do About It)” By Marcia Angell (2004/2005), former Editor of The New England Journal of Medicine. I am now reading “Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients” by Ben Goldacre (2012/2013), University of Oxford.
… I am still a “newbie” (computer-geek term for “beginner” in all this, but already it seems like “…here we go again!” with Hepatitis C.
Will it ever end?
Maybe it is ultra-naive of me to say this, but the computing world used to be dominated by companies like IBM and Microsoft, and then along came completely new models of doing business Linux, Google. etc. (sure, they still make big bucks, but they add value!)
… My point being that its impossible to change the old dinosaurs (i.e. you can’t teach an “old dog new tricks”, but IT IS POSSIBLE TO INTRODUCE NEW SOLUTIONS which quickly gain acceptance because they actually work for people…
So even if we love to knock the dinosaurs, we should also be thinking about how to achieve a better solution beyond Big Pharma?
In the development of computing, the internet did not wait for dinosaurs. Let’s now use the internet for human health!
Diagnosed Jan 2015: GT3, A0+F0/F1. Fatigue + Brain-Fog.
Started Sof+Dac from fixHepC 10-Nov-2015. NO sides.
Pre-Tx: AST 82, ALT 133, Viral Load 1 900 000.
Week4: AST 47, ALT 58. VL < 15 (unquantifiable). Week12 (EOT): AST 30, ALT 26, VL UND Week16 (EOT+4): AST 32, ALT 28, GGT 24, VL UND Week28 (EOT+16): AST 26, ALT 22, GGT 24, VL UND Ever grateful to Dr James. Relapsed somewhere after all that... Bummer! Jan 2018: VL 63 000 (still GT3).22 November 2015 at 2:51 am #4398Leunig lives close to clifton hill and many a time we wait at the lights. i try to discreetly purve on the fine mind and ignore at the same time- just another clifton hill dude.
22 November 2015 at 4:11 pm #4428Yes, that’s the same blythe tone that has got me too, when they tell you that you’ll have to wait for an indefinite time for treatment, or they announce that you relapsed but never mind because more expensive drugs are coming soon that you’ll have to wait for. Or they tell you they’ll apply for a care home place for you that you’ll have to wait for – and to meanwhile order up your groceries via home delivery if you can’t manage your shoppng. Or they give your name to the undertaker, except you don’t hear it that time.
We used to just be ‘warehoused’. Nothing moved.
Now we are on the conveyor belt. A very long one. Moving but still no progress.When you hear that blythe tone watch out because it only means one thing for you – the situation is so dire that we’re all going to pretend that everything is aok.
I can’t think of any company in recent times that has attracted so much hatred, even Big polluting Oil. If there is such a thing as karma then they’ll get theirs, but I’m not sure it works that way. I agree with you Vororo that new solutions are our best hope for that.
dt
22 November 2015 at 4:32 pm #4431And while I am at it, let’s not forget about the founders of Pharmasset who sold out to Gilead for 11B. They had an exceptionally brilliant company and developed sofosbuvir in the first place. They knew what they had, ie. the backbone of all ifn-free combos to come for the foreseeable future. As in – they knew they had the future medical equivalent of the internet. They also had a choice. Take the money and run, or take less money but ensure that sofosbuvir would be used in a humanitarian way. The GREED started with THEM.
https://en.wikipedia.org/wiki/Pharmasset
dt
22 November 2015 at 5:01 pm #4439Difficult to think otherwise, isn’t it DT?
And now Michael Sofia, the inventor of Sofosbuvir, is lamenting the fact that not all sufferers are able to access the drug
[video]https://www.youtube.com/watch?v=rYzsUOLaekI[/video]
And from the wiki article
When Gilead Sciences acquired Pharmasset for $11 billion in 2012, the “smaller company had forecast a $36,000 price per treatment course of Sovaldi. Gilead’s investment bankers, Barclays and Bank of America Merrill Lynch did the “valuation of Pharmasset during merger talks and the related pricing assumptions for Sovaldi.” According to the The Wall Street Journal in response to the price of Solvadi at $84,000 per treatment course, the United States Senate Finance Committee wrote a letter to CEO John C. Martin questioning how much Pharmasset had spent on research and development on Sovaldi and how much Gilead spent on its “Sovaldi-related research costs since the 2012 buyout
GT1a since 1988, diagnosed 1990
F0, tx naive
VL 262,000 ALT 40 AST 26 GGT 13 Fibroscan 04/12/15 – 2.9
Started Mesochem sof/dac 12 weeks 01/01/2016
11/02/2016 – 6 weeks UNDETECTED
AST 26
ALT 26 -
AuthorPosts
- You must be logged in to reply to this topic.